News Focus
News Focus
icon url

oldberkeley

01/06/11 4:40 PM

#1201 RE: 10nisman #1200

After today's Teva presentation I'm starting to favor choice #2.

I know that you're joking about "starting over", but I think that whatever news the FDA delivers, it won't be good for Teva.

As long as the media/analysts/whomever spins this news in a reasonably truthful and accurate manner (the best we can hope for) things should be looking up for MNTA.

Best of luck.

Addendum: I just read poorgradstudent's post on the BV board, he's expecting Teva to get a "to-do list" from the FDA in January.
icon url

floblu14

01/06/11 4:46 PM

#1202 RE: 10nisman #1200

On the other HAND -

Select any 6:

1. Younger Kwon is hired away by Teva.

2. Homeless, transgenic GTC Goats rampage through Cambridge.

3. Henri T. pulls the wrong switch causing a cerezyme tsunami inundating MNTA headquarters.

4. R. Shea becomes the new speech pathologist for the KING'S SPEECH.

5. B. Marth knowingly takes a "bath" in Teva's generic Lovenox & reappears as a munchkin at Dunkin' Donuts.